PMID: 9554686Apr 29, 1998Paper

End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy

Archives of Internal Medicine
D R Powers, J D Wallin

Abstract

During the past few years, it has become apparent that there are factors that place a person at greater risk for the development and progression of renal failure. This has been documented since the early 1980s by the United States Renal Data System that has collected data confirming that end-stage renal disease occurs at a greater rate in certain subpopulations of Americans. It is evident from an examination of the data that African Americans and American Indians have an incidence of end-stage renal disease that is not proportional to their percentage of the total population. In fact, African Americans and American Indians are reported to have at least a 4-fold greater incidence of end-stage renal disease than white Americans. There have been 5 factors identified: hypertension, glucose intolerance, insulin resistance, salt sensitivity, and hyperlipidemia, which may play a greater role in these subpopulations. In addition, as with other populations, lifestyle issues may serve to alter these primary risk factors or may act as direct modulators of renal disease progression. There is also a possibility that interactions between risk factors frequently occur that may modify the development or progression of the disease. This article...Continue Reading

Citations

Jul 1, 2006·Future Cardiology·Albert Yuh-Jer ShenDean A Kujubu
Jan 30, 2004·QJM : Monthly Journal of the Association of Physicians·R M FrancisA Rodgers
Nov 13, 2004·Current Diabetes Reports·Errol D Crook, Sejal R Patel
Mar 20, 2003·Current Diabetes Reports·Donald W Bowden
Mar 29, 2002·American Journal of Public Health·David R Williams
Dec 15, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Kimberly Y Z ForrestJane A Cauley
Jan 20, 2004·Advances in Renal Replacement Therapy·Suying LiAllan J Collins
Jan 11, 2012·Age and Ageing·Morten FrostKim Brixen
Sep 24, 2008·American Journal of Public Health·David R Williams
Sep 13, 2012·European Journal of Endocrinology·G MazziottiA Giustina
Jan 16, 2010·Expert Opinion on Drug Metabolism & Toxicology·Subhashis ChakrabortySanjay Singh
Apr 13, 2005·Blood Pressure·A Mimran, M R Weir
Feb 28, 2002·The American Journal of the Medical Sciences·Errol D Crook
Nov 25, 2003·Kidney International·Robert B Toto
Sep 8, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R B IsaacsT L Pruett
Jan 28, 2010·Acta Clinica Belgica·L D KolaJ M Krzesinski
Aug 17, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·O A MojiminiyiW A Aldhahi
Jan 5, 2002·The American Journal of Gastroenterology·K N LimC J Bruno
Aug 5, 2011·Journal of Clinical Gastroenterology·Robert John WongCatherine Frenette
Jul 20, 2007·Journal of the American Society of Nephrology : JASN·Luigi GnudiGiancarlo Viberti
Jan 6, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Janice G Douglas
Dec 28, 2007·The Journal of Clinical Endocrinology and Metabolism·Roberto BaldelliSilvia Grottoli
Sep 12, 2000·Current Hypertension Reports·R K Wali, M R Weir
May 16, 2006·The Journal of Cardiovascular Nursing·Marie N FongwaLynn V Doering
Sep 21, 2002·The American Journal of the Medical Sciences·Errol D CrookJohn Hall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.